Related Experiment Video
Updated: Jun 3, 2025

Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization
Published on: July 27, 2021
Mathematical bounds on r 2 and the effect size in case-control genome-wide association studies
Sanjana M Paye1, Michael D Edge1
1Department of Quantitative and Computational Biology, University of Southern California.
Optimizing case fractions in genome-wide association studies (GWAS) is crucial for statistical power. Our model shows how varying case numbers impacts detecting genetic associations, depending on allele characteristics.
Area of Science:
- Population Genetics
- Statistical Genetics
- Genomic Epidemiology
Background:
- Case-control genome-wide association studies (GWAS) are fundamental for identifying genetic variants linked to diseases.
- Study design decisions, particularly the ratio of cases to controls, significantly influence the statistical power of GWAS.
- Allele frequencies and linkage disequilibrium (LD) impact association statistics, and these are affected by the case fraction.
Purpose of the Study:
- To investigate how varying the proportion of cases in a case-control GWAS affects the statistical power to detect genetic associations.
- To extend existing knowledge on bounds of LD statistics to understand the impact of case fraction on power.
- To provide a framework for optimizing study design based on allele characteristics.
Main Methods:
- Analysis of a mathematical model incorporating allele frequencies and LD.
- Simulations to evaluate a quantity proportional to the non-centrality parameter of association tests.
- Exploration of effects under varying conditions of dominance, penetrance, and allele frequency.
Main Results:
- The case fraction significantly influences the non-centrality parameter and, consequently, statistical power.
- The impact of case fraction on power is dependent on the specific genetic architecture of the risk allele (dominance, penetrance, frequency).
- Observed power asymmetries for risk versus protective alleles and non-optimal power with balanced samples for certain allele types are explained.
Conclusions:
- The optimal case fraction in GWAS is not always 1:1 and depends on the genetic properties of the variant.
- This framework offers insights into optimizing GWAS design for enhanced detection of disease-associated genetic variants.
- The findings are applicable as a guide for statistical power in various association tests beyond chi-squared tests.
More Related Videos
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Hardy-Weinberg Principle
Accuracy and Errors in Hypothesis Testing
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5%...
Chi-square Analysis
The chi-square test was developed by Pearson in 1990.
The first step of performing a Chi-square analysis is to establish a null hypothesis, which assumes that there is no real...
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...

